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Cyclosporin A (CsA), a potent inhibitor of T-cell activation, has been shown to have several
effects on thymocyte maturation, thymic stromal cells, and the generation of autoreactive T
cells. In Lewis rats, the combination of lethal irradiation, syngeneic bone marrow
transplantation, and a 4-week course of CsA administration causes the development of an
autoimmune disease (CsA-AI) resembling allogeneic graft-versus-host disease. This occurs
upon withdrawal of CsA, provided the thymus receives irradiation and is present during
CsA treatment. In this study, the separate effects of irradiation or CsA treatment on thymic
stromal cells and thymocytes, compared to the combinatory effects, were examined using
immunohistochemistry and tricolor flow cytometric analysis.
CsA treatment causes an involution of the thymic medulla and a strong reduction of the
cell number of thymocytes and stromal cells residing in the medulla. However, within the
remaining medullary area, changes in cell distribution and antigen density on these cells
were not observed. Irradiation on the other hand causes a strong depletion of thymocytes.
The thymocyte population is recovered within 2 weeks and a cortical and medullary region
can be distinguished. CsA treatment in combination with irradiation results in a strongly
inhibited recovery of the medulla during CsA treatment, whereas the cortex recovers to
normal size and morphology. The presence of the medullary IDC and epithelial cells is
reduced proportionally to the small size of the medulla. However, the distribution of these
stromal cells is normal. During the CsA administration, the thymuses from irradiated and
CsA-treated rats are very similar to thymuses from CsA-treated rats. In conclusion, no
changes specific for irradiation plus CsA treatment have been observed. Regarding the
distribution and size of medullary stromal cells and residing thymocytes, thymuses from
irradiated and CsA-treated rats hardly differ from the thymuses from rats treated only with
CsA. Therefore, irradiation seems essential in the generation of CsA-AI by eliminating
suppressor-cell circuits in the periphery.
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INTRODUCTION
The fungal metabolite cyclosporin A (CsA) is a
very potent immunosuppressive drug that pre-
dominantly acts on T-cell-dependent responses
(Schreiber and Crabtree, 1992). It is effectively used
in preventing graft rejection and graft-versus-host
disease (GVHD) secondary to allogeneic bone mar-
row transplantation (BMT). Although CsA is also
very useful in inhibiting the progression of several
autoimmune diseases, surprisingly, autoimmune
phenomena may rise upon withdrawal of CsA
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treatment under certain conditions. Rats treated
with CsA after lethal irradiation and consecutive
syngeneic BMT develop GVHD-like lesions after
CsA administration is stopped (Glazier et al., 1983);
in humans, too, similar lesions have been reported
after autologous BMT (Jones et al., 1989). The
crucial role of the thymus in the induction of this
CsA-induced autoimmunity (CsA-AI) has unequiv-
ocally been established (Sorokin et al., 1986; Wodzig
et al., 1993).
Immunosuppression with CsA not only effec-
tively blocks the proliferation of mature peripheral T
cells, but also blocks thymocyte maturation (re-
viewed by Ritter and Boyd, 1993). Maturation of
cortical CD4 + CD8 + (double-positive) thymocytes
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into medullary CD4 + and CD8 + (single-positive)
thymocytes is strongly inhibited (Gao et al., 1988;
Jenkins et al., 1988; Kanariou et al., 1989). Immu-
nohistochemical analysis of CsA-treated thymuses
from rodents shows a relatively small medulla, in
which the loss of medullary thymocytes is accom-
panied by a loss of medullary stromal cells (Tanaka
et al., 1988; Schuurman et al., 1990; Ritter and
Ladyman, 1991) and formation of large areas de-
nuded of MHC class-II positive epithelial cells
(Bruijntjes et al., 1993). The medullary stromal cells,
consisting of epithelial cells, macrophages (M)), and
interdigitating cells (IDC), play an important role in
negative selection of autoreactive cells. The absence
or functional alteration of medullary stromal cells
has been suggested to lead to the escape of possible
autoreactive cells to the periphery and the develop-
ment of autoimmunity (Schuurman et al., 1990;
Beschorner and Armas, 1991a; De Waal et al., 1992).
Although upon CsA administration in the rat
autoreactive T cells are generated (Beschorner et al.,
1988b) and in the mouse the peripheral occurrence
of T cells bearing self-reactive T-cell receptors, as
determined by the use of mAbs recognizing specific
"forbidden Vfs", has been demonstrated (Jenkins et
al., 1988), only the combination of CsA and irradi-
ation evokes CsA-AI in the rat. Lethal irradiation, in
terms of complete bone marrow depletion, has
numerous effects on the immune system, but syn-
geneic BMT normally leads to an almost complete
recovery of the thymus (Mulder and Visser, 1988;
Mulder et al., 1988; Murawska et al., 1991). Irradi-
ation wipes out almost the whole thymocyte popu-
lation, whereas the thymic stromal cells are
relatively radio-resistant. Shielding of the thymus
during irradiation prevents disease both in rat (Be-
schorner et al., 1987) and in mouse (Cheney and
Sprent, 1985). It has been suggested that both
whole-body irradiation, including the thymus and
the CsA treatment have effects on the thymus
essential for the induction of CsA-AI. Alternatively,
post-CsA prevention of thymic recovery by thymec-
tomy in unirradiated rats consistently evokes CsA-
AI (Beschorner et al., 1991b). This implies that the
effect of irradiation can be replaced by thymectomy
after the CsA treatment, suggesting that a normal
thymic microenvironment after CsA is necessary to
reestablish self-tolerance through autoregulatory
cells.
In our rat model, the combination of CsA and
irradiation evokes CsA-AI, so this study was de-
signed to determine the differential effects of CsA
and irradiation on the thymus, as compared to the
combinatory effects. The attention was focused on
(1) the presence and immunohistochemical proper-
ties of the thymic stroma with special reference to
the medullary IDC and epithelial cells and (2) the
number and phenotype of thymocytes during and
after CsA treatment. Furthermore, the disease-
inducing effects of the separate treatments in com-
bination with thymectomies were determined.
RESULTS
Thymus Morphology and Thymocyte Number
The thymus was morphologically assessed for the
relative size of the medulla and for thymocyte
density within the cortex and medulla with hema-
toxylin and eosin sections. The thymocyte number
was determined by counting single-cell suspensions
in a Birker hemocytometer.
Total body irradiation with 8.5 Gy caused a
collapse of the thymic architecture and a strong
reduction of thymocytes within 48 hr. Whereas the
medulla seemed only slightly affected, the cortical
thymocytes had completely disappeared. One week
after irradiation, there was hardly any cortex or
medulla detectable, but as soon as 2 weeks after
irradiation, a new cortex was formed together with
a small medulla.
Two days after irradiation, the total number and
viability of thymocytes were very low. During the 2
weeks following irradiation, thymocyte cell number
increased from 1.2 x 107 at week 1 to + 40 x 107 at
week 2. Thereafter, the cell number increased much
slower (Fig. 1). This thymocyte recovery was in
harmony with morphological restoration of the thy-
mus. There was little difference in total thymocyte
number between SYN+ or SYN- rats, but the
differences in the cortex/medulla ratio were drastic.
Two weeks after irradiation, the medulla in the
SYN+ thymus was very small compared to SYN-
and AMC- but resembled the AMC+ thymus. As
soon as 1 week after the daily administration of 7.5
mg CsA/kg, a reduction of the thymic medullary
area was noticed in AMC+ thymuses. Two weeks
after the initial administration, the reduction was
maximal and remained the same at least until 1
week after the 4-week course of CsA-administration
had been terminated, both in SYN+ and AMC+
thymuses. The cortical area recovered within 2
weeks after irradiation and seemed to be unaffected
by CsA in SYN+ thymuses.CYCLOSPORIN INDUCED AUTOIMMUNITY 129
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in the medulla, as was the expression of MHC class
and II, ICAM-1, ED1, and ED8. Therefore, the
expression of these markers is very indicative for the
presence of IDC in SYN+ thymuses, as well as
AMC+ thymuses from 2 weeks after irradiation
onwards. In SYN- thymuses as soon as 2 weeks
after irradiation normal distribution and expression
of medullary IDC antigens was seen (Fig. 2).
A partial recovery of the medullary size in SYN+
and AMC+ thymuses was observed at 2 weeks ater
cessation of the CsA treatment together with a
recovery of medullary stromal cells expressing ED1,
ED8, OX6, OX18, OX39, and OX62.
FIGURE 1. Average of total number of viable thymocytes Thymi Epithelial Cells
isolated from two thymuses per group (AMC-: open squares;
AMC+: open circles; SYN-: closed squares; SYN+: closed A panel of mAbs recognizing thymic epithelium
circles) at the time indicated. Cell numbers were assessed using a
Birker Hemocytometer. From week 6 and later when CsA-AI was used to examine different subsets of epithelial
developed, two SYN+ animals free of macroscopical signs cells. The mAbs HIS37 and RCK 102, both pan
(SYN+) and two animals with clear signs of dermatitis epithelial cell markers in the thymus, visualized
(SYN + CsA-AI: dotted line) were assessed,
three different areas with regard to the presence and
morphology of epithelium: (1) the medulla with
Interdigitating Cells epithelial cells most abundantly present in the cor-
ticomedullary region, (2) the cortex with the fine
We used a set of mAbs reactive with IDC in the reticular epithelium, and (3)the epithelial-free areas
thymic medulla. Most of these mAbs, however, are closely located to the capsule surrounding the thy-
not specific for IDC, but additionally react in the mus and the protruding septae. Furthermore, mAbs
thymus with epithelial cells (OX6, OX18, 1A29), M) HIS38 and ED19 recognize cortical epithelial cells,
(ED1, ED8, 1A29, OX6, OX18), or thymocytes whereas HIS39 and ED20 are specific for medullary
(OX18). The diffuse staining patterns of the mAbs epithelium. The epithelial cells are also detected by
recognizing epithelial cells or Mq besides IDC in the the earlier mentioned mAbs OX6, OX18, and 1A29.
thymic medulla made it difficult to distinguish be- In SYN + rats, the cortical restoration seemed
tween the different cell types. Especially mAbs normal. HIS38 as well as ED19 clearly showed
OX39 and OX62, which in the thymic medulla the cortical area, which was very extensive after 2
recognize specifically IDC, appeared to be very weeks. However, a combination of changes in
useful for the identification of this cell type. thymic architecture was observed (see Table 1).
As mentioned before in SYN+ rats, the thymic Epithelial-free areas (EFA) close to the septae and
architecture was perturbed by irradiation, and the capsule became very flat. Furthermore, after 2
medulla recovery was strongly inhibited by the CsA weeks, vast areas void of epithelium developed
treatment. As in SYN- thymuses, the effects of surrounding the medulla. The medulla remained
irradiation were very drastic; 1 week after irradia- relatively small as determined by the medullary
tion a clearly detectable medulla was absent. A1- epithelium markers HIS39 and ED20. Thymuses
though the IDC antigens were present, it was from SYN+ rats showed no difference in the
impossible to determine whether it concerned cell epithelium cell pattern compared to AMC+ thy-
debris or viable cells. Morphologically, normal cells muses at 2 weeks after irradiation, except for the
expressing OX6, OX18, OX39, or OX62 were not absence of the flat EFAs close to the septae and
detectable in the medulla. However, in SYN+ rats, capsule in the AMC+ thymuses. Overall, these
a small medulla could be detected as soon as 2 changes were especially clearly visualized by the
weeks after irradiation (Fig. 2). The medulla of mAb OX6, recognizing MHC class II present on
SYN+ thymuses was of comparable size as in epithelial cells, MG and IDC (Fig. 3). In SYN-
AMC+ thymuses. OX62-positive cells and OX39- rats, irradiation damage seemed restored within 2
positive cells were present in a normal distribution weeks. Typically, the EFAs close to the septae andCYCLOSPORIN INDUCED AUTOIMMUNITY 131
TABLE
Thymocyte Numbers
(Fig. 1)
Relative Amount Septae- Medullary-
TCRc]-high cells (Fig. 4) related EFA related EFA
AMC- Normal; steady
AMC + Normal; steady
SYN- Decreased, slow, and
incomplete recovery
SYN + Decreased, slow and
incomplete recovery
Normal; about 10% Normal Absent
Decreased until week 3, slow Normal Present
recovery
Normal from week 2 Flat Absent
Decreased until week 3, slow Flat Present
recovery
capsule were very flat as in SYN+ thymuses, but
the epithelial-free areas around the medulla were
not observed.
Macrophages
The presence of macrophages was examined with
mAbs ED1 (monocytes, M(, and IDC) and ED2
(cortical M)).
In SYN+ and SYN- thymuses 48 hr after
irradiation in the cortex, the relatively radio-
resistant Mq were packed very densely against
each other due to the disappearance of cortical
thymocytes. As soon as 2 weeks after irradiation,
ED1- and ED2-positive M were normally distrib-
uted throughout the cortex, both in SYN + and
SYN- thymuses. In AMC+ thymuses ED2 distri-
bution in the cortex was not disturbed by CsA.
ED2-positive cells never were observed in the
medulla, as identified by the localization of the
morphological difference between cortical and
medullary thymocytes, in any of the thymus sec-
tions of all four groups studied. In the EFAs
surrounding the medulla, ED1- and ED2-positive
cells were present in a normal distribution, com-
parable to the ED1 and ED2 distribution in the
cortex. The distribution of EDl-positive Mq in the
medulla was normal 2 weeks after irradiation and
seemed unaffected by the CsA treatment.
Thymocytes
The thymocytes have been studied with OX19, R73
(both expressed low in the cortex and high in the
medulla), HIS45 (specific for medullary thymo-
cytes), OX8, and W3/25 (in the cortex, all thymo-
cytes are positive, whereas in the medulla,
approximately two-thirds are W3/25-positive and
one-third is OX8-positive). The antigen expression
recognized by these mAbs was not changed in any
of the observed thymic sections at any time. The
only difference was observed in the distribution. In
SYN+ thymuses 2 weeks after irradiation, a normal
cortex and a small medulla could be detected in
AMC+ thymuses. In the epithelial-free areas in the
vicinity of the medulla, as formed by the CsA
treatment, and in the epithelial-free areas close to
the septae and capsule, the thymocytes had a
cortical phenotype. In SYN- and AMC- thymuses,
the distribution was normal. Overall, the distribu-
tion described was according to the stromal-cell
distribution defining cortex and medulla. After ces-
sation of the CsA treatment, both SYN+ and
AMC + thymuses gradually recovered as stated
before, and the distribution of cortical and medul-
lary thymocytes resembled the normal situation. At
the onset of disease, a disturbance in thymic mor-
phology was observed affecting cortex and medulla
(as described by Beschorner et al., 1988a). This was
associated with a reduction of thymocyte number
(Fig. 1) and a decrease of thymic size.
By tricolor flow cytometry, we studied the thymo-
cyte populations with respect to the antigens CD4,
CD8, and TCR(x[. In SYN+, the number of TCRc[-
high positive thymocytes remained very low during
CsA administration (Fig. 4), whereas in SYN- the
strong depletion of the thymocytes was overcome
as soon as 2 weeks after irradiation (Fig. 4). In
AMC+, the TCR(-high positive thymocytes also
diminished upon CsA administration (Fig. 4). Tri-
color analysis showed that in SYN+ and AMC+
thymuses, the medullary CD4+TCRc[-high and
CD8+ TCRc[-high thymocytes disappeared,
whereas the cortical CD4+CD8+TCRc[- intermedi-
ate thymocytes were unaffected (Fig. 5). After the
CsA treatment was stopped, the number of CD4+
TCR([-high and CD8+TCR(x[-high cells started to
normalize in SYN+ and AMC+ thymuses. As CsA-
AI developed, the total number of thymocytes
was reduced, but the relative number of CD4+
TCRc]-high and CD8+TCR(]-high cells remained
the same. All these changes in thymocyte132 L.J.J. BEIJLEVELD et al.
FIGURE 3. Thymuses from AMC- (A, B), AMC + (C, D), SYN- (E, F), and SYN + (G, H) rats at 2 and 4 weeks after initiation of
the experiment. Sections were stained with mAb OX6 recognizing MHC class II (RTIB) present on epithelial cells and IDc. (A, C, E,
and G) Week 2; (B, D, F, and H) week 4. E: epithelial-free areas void of MHC class II; C: cortex with fine reticular epithelium; M:
medulla with IDC and epithelium. In (C and D) (AMC + and (G and H) (SYN + ), arrows are indicating the small medullary remnants.CYCLOSPORIN INDUCED AUTOIMMUNITY 133
relative number of TCRel-high+ thymocytes
16%-
14%-
12%-
10%-
8%-
6%
4%
2%
0%
week 0 week 2 wee
SYN +
I\ = SYN
\ --o--- AMC +
stop CsA
k 4 week 6 week 8
post BMT
FIGURE 4. Relative number of
TCR-high thymocytes. Every week
thymocytes were assessed for their
expression of CD4, CD8 and TCR
using tricolor flow cytometry. By us-
ing a life gate, 10,000 cells per sample
were analyzed. Per group, two thy-
muses were analyzed and the average
relative amount of TCR(-high posi-
tive thymocytes is shown. AMC-
thymuses were assessed from week 0,
thymuses of AMC+, SYN- and
SYN+ rats were tested from week
until week 8.
AMC AMC * SYN +
CD8
ICD4
FIGURE 5. By tricolor flow cytometry, the CD4, CD8, andTCR( expressions of thymocytes, isolated from thymuses at week 4, were
assessed. By using a life gate, 10,000 cells per sample were analyzed. The first column shows the analysis of a control thymus (AMC-);
in the second column, a CsA-treatd thymus (AMC+) is analyzed., and in the third column, a thymus from an irradiated and
CsA-treated rat (SYN + is analyzed. In the upper panels, the total expression of TCR( is shown. The middle panels show the dot
plot analysis of CD4 (FITC) and CD8 (PE) for the same thymocyte populations. Per quadrant, the TCR( expression is depicted in
the lower panels as CD4-CD8+ in quadrant 1, CD4+CD8+ in quadrant 2, CD4-CD8- in quadrant 3, and CD4+CD8- in quadrant
4. Notice the presence of TCR0-high positive cells in quadrant and 4 of the AMC- thymus and the absence of these cells in the
AMC + and SYN + thymuses due to the strong decrease of CD4 and CD8 single-positive thymocytes, rather than not expressing
TCR( by these cells.134 L.J.J. BEIJLEVELD et al.
population were in accordance with the changes
observed by immunohistochemistry.
The Effects of Thymectomies Performed After
Irradiation or CsA treatment
To evaluate the effects of an abrogated recovery
after irradiation or CsA treatment only, thymecto-
mies were performed. Because the presence of the
stromal microenvironment recovers in the second
week after irradiation, the possible generation of
autoreactive T cells during this period was evaluated
by thymectomies, preventing subsequently the gen-
eration of regulatory T cells in the thymus. At days
7, 10, and 14 after irradiation and consecutive BMT
each time, three SYN- rats were thymectomized
and observed daily for the development of CsA-AI.
None of these animals developed macroscopical
signs of CsA-AI within a period of 3 months after
thymectomy.
In order to test the alternative hypothesis that the
effect of irradiation can be replaced by thymectomy
after the CsA treatment, two groups of 12 AMC+
rats were thymectomized at day 28 directly after a
continuous course of CsA administration. Again, no
macroscopical signs of CsA-AI developed within a
period of 3 months after thymectomy.
DISCUSSION
The induction of CsA-AI requires the combination
of lethal irradiation and syngeneic bone marrow
reconstitution and the treatment with CsA for a
given period. Early after irradiation, the thymus
morphology is very much perturbed. Because the
thymocyte population has almost completely disap-
peared, stromal cells are densely packed. Therefore,
the presence and distribution of specific stromal cell
types are difficult to determine immunohistochemi-
cally. Two weeks after irradiation the thymus is
repopulated with thymocytes and a morphologically
distinguishable cortex and medulla are formed.
Whereas the cortex morphology and size are nor-
mal, the restoration of the medulla is strongly
inhibited by the CsA treatment. The presence of the
medullary IDC and epithelial cells is reduced pro-
portionally to the small size of the medulla; how-
ever, the distribution of these stromal cells in the
shrunken medulla is normal.
The effects of CsA on the thymus are still obscure.
CsA causes a strong involution of the thymic me-
dulla and a reduction of IDC in a dose-dependent
manner (Damoiseaux et al., 1993). There is increas-
ing evidence that CsA interferes with the early steps
in T-cell activation by inhibiting the transcription of
genes involved in cyt0kine production (Schreiber
and Crabtree, 1992). Similar events occur in the
maturation steps from cortical double-positive thy-
mocytes into single-positive medullary thymocytes.
A cascade of activation events is supposed to be
essential in which several cytokines are produced
(reviewed by Ritter and Boyd, 1993). It has been
shown that the medullary stroma is highly depen-
dent upon the presence of TCRc-high thymocytes
(Shores et al., 1991; Thomson, 1992). A cytokine-
driven network of factors produced by stromal cells
and thymocytes might be very important for the
maintenance of the medulla. The development of
medullary IDC probably is dependent on the pro-
duction of cytokines, such as GM-CSF and IL-2.
Therefore, an effect on thymocyte maturation prob-
ably also involves an influence on IDC maturation
and turnover. On the other hand, the thymocytes
are highly dependent on the stromal cells for their
selection. It has been suggested that the absence of
stromal cells in CsA-treated thymuses is responsible
for the leakage of autoreactive cells to the periphery.
In this study, we showed that the antigenic density
and distribution of these stromal cells are not dis-
turbed. Thus, the role of CsA in inhibiting negative
selection is not explained by this activity of CsA. It
has been described that CsA also inhibits apoptosis
(McCarthy et al., 1992; Yasutomi et al., 1992).
Therefore, it seems likely that thymocytes that are
no longer allowed to become activated due to the
presence of CsA escape apoptosis and leave the
thymus unselected. Although CsA treatment causes
the formation of "forbidden" possible autoreactive
T cells (Jenkins et al., 1988; Bryson et al., 1991), CsA
treatment alone is not sufficient to cause disease
(Beschorner et hl., 199 lb).
After irradiation and BMT, the presence of the
thymus is essential during the first 2 weeks of CsA
administration for the development of CsA-AI (So-
rokin et al., 1986; Wodzig et al., 1993). During this
period, the effects of irradiation must be overcome,
and a strong influx of thymocytes is observed. The
presence of medullary IDC is hard to determine and
it is tempting to suggest that a lack of negative
selection might occur during this period due to the
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resistant (Murawska et al., 1991) and thymectomies
of SYN- rats at 7, 10, or 14 days after irradiation
and BMT did not induce autoimmune phenomena.
Hence, the T cells that mature early after irradiation
in SYN- rats do not form an autoreactive popula-
tion capable of inducing autoimmunity as they do in
SYN+ rats.
Our data show morphological changes in thymic
architecture, especially in the distribution of cortex
and medulla. However, it seems that there are no
essential differences found in thymuses from irradi-
ated and CsA-treated rats compared to CsA-treated
rats, regarding the presence of thymic stromal cells.
Cells essential for thymic selection are present, and
the phenotype of the stromal cells and thymocytes is
normal. At the onset of disease, the thymus seems
to be one of the organs affected in CsA-AI. Thymus
morphology shows that this effect probably is not
mediated by corticosteroids as induced by a stress
response, but that the thymus is one of the target
organs of CsA-AI (Beschorner et al., 1988a). Al-
though we know that the thymus is allowed to
recover after irradiation, albeit in an altered fashion
due to CsA administration, very often no thymic
remnants are found in the late acute phase of
disease. In SYN+ rats, thymectomies performed
directly after the cessation of CsA administration do
not influence the course of disease, indicating the
essential role for the thymus early after irradiation
during CsA treatment, bat not in the period there-
after. Inability to recover after CsA cessation, how-
ever, is not an explanation for development of
disease as stated by others (Beschorner et al.,
1991b), because in our study thymectomies per-
formed directly after the cessation of CsA treatment
in AMC+ rats do not cause CsA-AI. Because irra-
diation is essential to evoke CsA-AI, it is likely that
there is an additional effect on the peripheral im-
mune system that normally suppresses effectively
autoreactive T cells leaking from the thymus during
CsA treatment. The role and characteristics of this
peripheral counterpart are under current investiga-
tion and may elucidate the contributions the thymus
provides in the induction of CsA-AI.
MATERIALS AND METHODS
Animals
Female, specific pathogen-free Lewis (LEW, RT1 I)
rats were used. The animals were obtained from
our own breeding colony and were fed ad libitum.
Animals were 6 weeks of age at the start of the
experiment. For the collection of the thymus and
bone marrow, rats were killed by cervical disloca-
tion under ether anesthesia.
Protocol for the Induction of CsA-AI
The experimental protocol has been described
before (Bos et al., 1988). In brief, rats were given
8.5 Gy at 0.5 Gy/min using a R6ntgen irradiator
(Philips MG320, Hamburg) 1 day prior to synge-
neic BMT. Bone marrow was collected from tibias
and femurs in balanced salt solution (BSS) supple-
mented with 2% heat-inactivated fetal calf serum,
penicillin (100 U/ml), and streptomycin (100 tg/
ml). Recipient rats were given 6 x 107 viable nu-
cleated syngeneic bone marrow cells in 1.0 ml BSS
intravenously into a tail vein. CsA, a kind gift
from Sandoz Pharma Ltd. (Basel, Switzerland),
was dissolved in olive oil at a concentration of 7.5
mg/ml. Rats received 7.5 mg CsA/kg-day, admin-
istered subcutaneously for 28 days.
Thymectomies
While under ketamin and xylazine anesthesia, rats
were intubated and maintained on a respirator. The
thorax was opened by mediastinal incision and the
thymus was entirely removed.
Experimental Design
In the first experiment, the immunohistochemistry
of the thymus was studied. Rats treated according to
the previously mentioned protocol (SYN+) were
compared to three different age-matched control
(AMC) animals: rats irradiated and syngeneic bone
marrow reconstituted and treated with olive oil only
(SYN-), rats only treated with CsA (AMC+), and
rats administered olive oil only (AMC-) (Table 2).
Two rats from each group were sacrificed at 48 hr
after irradiation and consecutive BMT and thereafter
weekly starting from day 7 for up to 8 weeks.
TABLE 2
Irradiation Syngeneic BMT Cyclosporin A
SYN + + + +
SYN + +
AMC + +
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In the second experiment, the thymocyte popula-
tion was studied by flow cytometry. Rats were
treated similarly. The thymuses were collected at the
same time points and prepared for flow cytometry.
The third experiment was designed to evaluate
the disease-inducing effects of the separate treat-
ments in combination with thymectomies. Thymec-
tomies were performed on three different time
points (days 7, 10, and 14) after irradiation and
consecutive BMT (SYN- rats) or directly after ces-
sation of a 4-week course of CsA administration
(AMC+ rats).
Antibodies
The mouse anti-rat monoclonal antibodies (mAb)
used for immunohistochemistry are specified in
Table 3. 1A29 was kindly provided by Prof. M.
Miyasaka (Tokyo). The ED series was kindly pro-
vided by Dr. C.D. Dijkstra (Amsterdam). The set of
HIS mAbs was kindly provided by Dr. J. Kampinga
(Groningen, the Netherlands). W3/25 and the OX
mAbs were obtained from the European Collection
of Animal Cell Cultures (Salisbury, UK). OX62 was
kindly provided by Dr. M. Brenan (Oxford), and R73
was kindly provided by Prof. Th. H(inig (Wirzburg,
Germany). RCK102 was obtained from Organon
Teknika (the Netherlands).
Immunohistochemistry
The thymus was snap frozen in isopentane and
used for cryosections. Four- to six-tm-thick thymus
cryosections were cut, air dried, and stored at
-20C. All thymus sections were stained using a
two-step immunoperoxidase technique after acetone
fixation. Sections were incubated for 60 min with
mAb in the appropriate dilution. After washing in
PBS, slides were incubated with a 1:200 dilution of
rabbit anti-mouse Ig peroxidase conjugate (Dako,
Denmark) in PBS with 0.5% bovine serum albumin
(w/v) (BSA, Sigma) and 3% normal rat serum (v/v)
for 30 min. After washing with PBS, the sections
were stained for peroxidase activity with 3,3’-
diaminobenzidine-tetrahydrochloride (Sigma, St.
Louis) (0.5 mg/ml, in Tris-HCI buffer (pH 7.6),
containing 0.02% (v/v) H202). Control sections
were incubated in the same way omitting the first-
step mAb. Subsequently, the sections were counter-
stained with hematoxylin, dehydrated, and covered
with Entallan (Merck, Germany).
Flow Cytometry
The thymus was teased apart and passed through a
100-t-mesh nylon gauze and collected in BSS sup-
plemented with 2% heat-inactivated new born calf
TABLE 3
mAb Antigen and Expression in the Thymus Reference
1A29
ED1
ED2
ED8
ED19
ED20
HIS37
HIS38
HIS39
HIS45
OX6
OX8
OX18
OX19
OX39
OX62
R73
RCK102
W3/35
ICAM-1, present on IDC and epithelium
Macrosialin, present in M( and IDC
Cortical
Complement receptor type 3, present on IDC, M( and granulocytes
CTES III
CTES II
CTES
CTES III
CTES II
Medullary thymocytes
MHC class II (RTIB), present on IDC, epithelium, andM
CD8, present on all cortical and a subset of the medullary thymocytes
MHC class (RTIA), present on all cells with high expression on epithelium, MG
and IDC
CD5, pan T-cell marker present on all thymocytes
Interleukin-2 receptor, present on T blasts and IDC
Integrin-like structure, present on IDC
T-cell receptor
All types of keratin, not species-specific
CD4, present on all cortical thymocytes, a subset of medullary thymocytes and
CTES: cluster of thymic epithelial staining
CTES Pan epithelial cells
CTES II Subscapsular/perivascular and the majority of medullary epithelail cells
CTES III Cortical epithelial cells including thymic cells (TNC)
CTES IV Hassall’s corpuscles and all medullary epithelial cells
CTES IV Hassall’s corpuscles and, sometimes, surrounding halo of medullary epithelial cells
Tamatani and Miyasaka, 1990
Dijkstra et al., 1985
Dijkstra et al., 1985
Damoiseaux et al., 1989
Kampinga et al., 1987
Kampinga et al., 1987
Kampinga et al., 1987
Aspinall and Kampinga, 1989
McMaster and Williams, 1979
Brideau et al., 1990
Fukumoto et al., 1982
Dallman et al., 1984
Paterson et al., 1987
Brenan and Puklavec, 1992
HOnig et al., 1989
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serum. These cells were kept on ice until all samples
were collected. The thymocytes were spun down
(316 g, 10 min, 4 C), resuspended in PBS containing
0.5% BSA, and counted in a B(rker Hemocytometer
while viability was assessed by trypan blue exclu-
sion. For tricolor flow cytometry, 5 x 105 cells per
sample were centrifuged in a 96-well microtiter
plate (236 g, 3 min, 4C) and resuspended in 20 tl
PBS containing 0.5% BSA, 10 mM NaN3, and the
following conjugated mAbs: ER2 (Joling et al., 1985)
conjugated to FITC (a kind gift from Dr. B. de Geus,
Leiden, the Netherlands) recognizing the rat CD4
antigen, OX8 conjugated to PE (Caltag, Hycult,
Uden, the Netherlands) recognizing the rat CD8
antigen, and R73 conjugated to biotin (a kind gift
from Prof. Th. H(inig, Wirzburg) recognizing the rat
T-cell receptor ( chain (TCR() and that is de-
tected in a second-step labeling by the streptavidin
conjugated fluorochrome Cy-Chrome (Pharmingen,
USA). By using these three labeled mAbs together
with the appropriate controls and by using optimal
settings and compensation, the expression of CD4,
CD8, and TCR( was determined on a FACSort
(Becton Dickinson).
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